⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8950133 | 0.83 | CA2 (0.36) | — | |
| SCHEMBL9058830 | 0.77 | — | — | |
| SCHEMBL8950135 | 0.71 | — | — | |
| SCHEMBL8950339 | 0.62 | CA2 (0.41) | — | |
| SCHEMBL10434124 | 0.57 | LMNA (0.57) | — | |
| SCHEMBL9110722 | 0.56 | LMNA (0.50) | — | |
| SCHEMBL10937950 | 0.55 | LMNA (0.55) | — | |
| SCHEMBL10004751 | 0.55 | LMNA (0.60) | — | |
| 2-Thiophenenecarboxaldehyde SCHEMBL7405336 | 0.55 | SMN1; SMN2 (0.39) | — | |
| SCHEMBL873415 | 0.54 | LMNA (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5538966-A | ENZYME INHIBITORS FOR TREATMENT OF GLAUCOMA | ALCON LABORATORIES, INC. (US) | 1996-07-23 | — | — | US | disclosed |